Matches in Nanopublications for { ?s ?p "TNF? also induced in HUVEC, a marked time- and dose-dependent stimulation of SAPK2/p38 that is characterized by an increased activity of MAPKAP K2/3, a direct physiological target of SAPK2/p38 (21). Maximal stimulation was obtained after a 10-min exposure to concentrations of TNFalpha equal to or higher than 5 ng/ml (Fig. 3,A and B). The pyridinylimidazole derivative SB203580, in concentrations of 1?5 ?m, completely inhibited the TNFalpha-induced increase in SAPK2/p38 activity as reflected by the inhibition of MAPKAP K2/3 activation in cells exposed to TNFalpha (Fig. 3 C). " ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- _6 value "TNF? also induced in HUVEC, a marked time- and dose-dependent stimulation of SAPK2/p38 that is characterized by an increased activity of MAPKAP K2/3, a direct physiological target of SAPK2/p38 (21). Maximal stimulation was obtained after a 10-min exposure to concentrations of TNFalpha equal to or higher than 5 ng/ml (Fig. 3,A and B). The pyridinylimidazole derivative SB203580, in concentrations of 1?5 ?m, completely inhibited the TNFalpha-induced increase in SAPK2/p38 activity as reflected by the inhibition of MAPKAP K2/3 activation in cells exposed to TNFalpha (Fig. 3 C). " provenance.
- _5 value "TNF? also induced in HUVEC, a marked time- and dose-dependent stimulation of SAPK2/p38 that is characterized by an increased activity of MAPKAP K2/3, a direct physiological target of SAPK2/p38 (21). Maximal stimulation was obtained after a 10-min exposure to concentrations of TNFalpha equal to or higher than 5 ng/ml (Fig. 3,A and B). The pyridinylimidazole derivative SB203580, in concentrations of 1?5 ?m, completely inhibited the TNFalpha-induced increase in SAPK2/p38 activity as reflected by the inhibition of MAPKAP K2/3 activation in cells exposed to TNFalpha (Fig. 3 C). " provenance.